MET and breast carcinoma: Thus, the combination of MET and DOX encapsulated in liposomesrepresents a promising therapeutic strategy for breast cancer treatment.Studies have shown that the release of MET in the tumor microenvironmentexerts antitumor effects by reducing hypoxia, HIF-1α, and P-glycoproteinexpression.